These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 19213856

  • 1. Lupus and T cells.
    La Cava A.
    Lupus; 2009 Mar; 18(3):196-201. PubMed ID: 19213856
    [Abstract] [Full Text] [Related]

  • 2. CD8alpha+beta(low) effector T cells in systemic lupus erythematosus.
    Werwitzke S, Tiede A, Jacobs R, Zielinska-Skowronek M, Buyny S, Schmidt RE, Witte T.
    Scand J Immunol; 2008 May; 67(5):501-8. PubMed ID: 18405327
    [Abstract] [Full Text] [Related]

  • 3. The busy life of regulatory T cells in systemic lupus erythematosus.
    La Cava A.
    Discov Med; 2009 Jun; 8(40):13-7. PubMed ID: 19772836
    [Abstract] [Full Text] [Related]

  • 4. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP, Krishnan S, Tsokos GC.
    Methods Mol Med; 2004 Jun; 102():31-47. PubMed ID: 15286379
    [Abstract] [Full Text] [Related]

  • 5. T cells in the pathogenesis of systemic lupus erythematosus.
    Hoffman RW.
    Clin Immunol; 2004 Oct; 113(1):4-13. PubMed ID: 15380523
    [Abstract] [Full Text] [Related]

  • 6. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus.
    Pernis AB.
    J Intern Med; 2009 Jun; 265(6):644-52. PubMed ID: 19493058
    [Abstract] [Full Text] [Related]

  • 7. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.
    Kammer GM.
    J Clin Invest; 2005 Apr; 115(4):836-40. PubMed ID: 15841173
    [Abstract] [Full Text] [Related]

  • 8. T cells as a therapeutic target in SLE.
    Comte D, Karampetsou MP, Tsokos GC.
    Lupus; 2015 Apr; 24(4-5):351-63. PubMed ID: 25801878
    [Abstract] [Full Text] [Related]

  • 9. T cell abnormalities in systemic lupus erythematosus.
    Takeuchi T, Tsuzaka K, Abe T, Yoshimoto K, Shiraishi K, Kameda H, Amano K.
    Autoimmunity; 2005 Aug; 38(5):339-46. PubMed ID: 16227148
    [Abstract] [Full Text] [Related]

  • 10. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype.
    Crispín JC, Kyttaris VC, Juang YT, Tsokos GC.
    Trends Immunol; 2008 Mar; 29(3):110-5. PubMed ID: 18249583
    [Abstract] [Full Text] [Related]

  • 11. Altered T and B lymphocyte signaling pathways in lupus.
    Peng SL.
    Autoimmun Rev; 2009 Jan; 8(3):179-83. PubMed ID: 18721908
    [Abstract] [Full Text] [Related]

  • 12. Altered signal transduction in SLE T cells.
    Tenbrock K, Juang YT, Kyttaris VC, Tsokos GC.
    Rheumatology (Oxford); 2007 Oct; 46(10):1525-30. PubMed ID: 17586862
    [Abstract] [Full Text] [Related]

  • 13. DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.
    Zhou Y, Lu Q.
    Autoimmun Rev; 2008 May; 7(5):376-83. PubMed ID: 18486925
    [Abstract] [Full Text] [Related]

  • 14. Systems biology in systemic lupus erythematosus: integrating genes, biology and immune function.
    Kyttaris VC, Krishnan S, Tsokos GC.
    Autoimmunity; 2006 Dec; 39(8):705-9. PubMed ID: 17178567
    [Abstract] [Full Text] [Related]

  • 15. Cellular immunity in systemic lupus erythematosus.
    Boumpas DT, Eleftheriades EG, Tsokos GC.
    In Vivo; 1988 Dec; 2(1):41-5. PubMed ID: 2979815
    [Abstract] [Full Text] [Related]

  • 16. Emerging concepts in the molecular pathogenesis of systemic lupus erythematosus.
    Nambiar MP, Juang YT, Tsokos GC.
    Arch Immunol Ther Exp (Warsz); 2002 Dec; 50(1):35-45. PubMed ID: 11916307
    [Abstract] [Full Text] [Related]

  • 17. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity.
    Sodsai P, Hirankarn N, Avihingsanon Y, Palaga T.
    Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637
    [Abstract] [Full Text] [Related]

  • 18. Pharmacotherapy of systemic lupus erythematosus.
    Francis L, Perl A.
    Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215
    [Abstract] [Full Text] [Related]

  • 19. IL-23: a promising therapeutic target for systemic lupus erythematosus.
    Leng RX, Pan HF, Chen GM, Wang C, Qin WZ, Chen LL, Tao JH, Ye DQ.
    Arch Med Res; 2010 Apr; 41(3):221-5. PubMed ID: 20682181
    [Abstract] [Full Text] [Related]

  • 20. The role of Ras signaling in lupus T lymphocytes: biology and pathogenesis.
    Mor A, Philips MR, Pillinger MH.
    Clin Immunol; 2007 Dec; 125(3):215-23. PubMed ID: 17913587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.